Hu14.18-interleukin-2 Fusion Protein at Medical Drugs Glossary

What is Hu14.18-interleukin-2 Fusion Protein? An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.

Medical Term & Definition Added By: Isabella

Send To Friends!

If you'd like to send the Hu14.18-interleukin-2 Fusion Protein definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -

We hope you now understand the meaning of Hu14.18-interleukin-2 Fusion Protein. If you need any more information on this term, please don't hesitate to contact us.

Other Similar Drugs Terms:

Prescription Drugs Term Ethical Pharmaceutical is A controlled substance for the diagnosis or treatment of disease.

Prescription Drugs Term stage IV gallbladder cancer is In stage IV, cancer has spread to nearby lymph nodes and/or to organs far away from the gallbladder.

Prescription Drugs Term cholelith is Solid material that forms in the gallbladder or common bile duct. Choleliths are made of cholesterol or other substances found in the gallbladder. They may occur as one large stone or as many small ones, and vary from the size of a golf ball to a grain of

Prescription Drugs Term blinded study is A type of study in which the patients (single-blinded) or the patients and their doctors (double-blinded) do not know which drug or treatment is being given. The opposite of a blinded study is an open label study.

Prescription Drugs Term CNS is Central nervous system. The brain and spinal cord.